BioStem Technologies notes FDA support for bayesian trial methods Feb 3, 2026 04:07PM
BioStem Technologies acquires BioTissue wound care business for $15 million Jan 21, 2026 05:33PM
BioStem Technologies comments on CMS rule withdrawal for wound products Jan 7, 2026 04:06PM
BioStem Technologies, Inc. (BSEM) Misses Q3 EPS by 23c Nov 13, 2025 04:08PM
BioStem Technologies files restated financial statements Nov 13, 2025 04:03PM


Aug 14, 2025 05:02PM BioStem Technologies, Inc. (BSEM) Misses Q2 EPS by 131c
May 13, 2025 05:05PM BioStem Technologies, Inc. (BSEM) Misses Q1 EPS by 24c
Apr 14, 2025 04:22PM BioStem Technologies, Inc. (BSEM) Tops Q1 EPS by 56c
Apr 1, 2025 04:51PM BioStem (BSEM) files for extension to submit 2024 annual report with OTC
Nov 12, 2024 07:39AM BioStem Technologies, Inc. (BSEM) Tops Q3 EPS by 6c
Aug 12, 2024 04:33PM BioStem Technologies, Inc. (BSEM) Misses Q2 EPS by 27c